Stability LPL II
A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
- Stadium
- klaar
- Middel
- darapladib
- Populatie
- ASCVD
- Fase
- III
- First Patient In
- 1 januari 2009
- Last Patient In
- 2 juni 2011
- Last Patient Last Visit
- -
Studiedirecteur
